Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Net Cash Flow (2020 - 2025)

Maravai Lifesciences Holdings has reported Net Cash Flow over the past 6 years, most recently at -$26.7 million for Q4 2025.

  • Quarterly results put Net Cash Flow at -$26.7 million for Q4 2025, up 89.56% from a year ago — trailing twelve months through Dec 2025 was -$105.5 million (up 58.24% YoY), and the annual figure for FY2025 was -$105.5 million, up 58.24%.
  • Net Cash Flow for Q4 2025 was -$26.7 million at Maravai Lifesciences Holdings, down from -$26.3 million in the prior quarter.
  • Over the last five years, Net Cash Flow for MRVI hit a ceiling of $172.9 million in Q3 2021 and a floor of -$255.8 million in Q4 2024.
  • Median Net Cash Flow over the past 5 years was -$2.2 million (2023), compared with a mean of -$958700.0.
  • Biggest five-year swings in Net Cash Flow: skyrocketed 1552.97% in 2021 and later crashed 5408.46% in 2024.
  • Maravai Lifesciences Holdings' Net Cash Flow stood at $3.5 million in 2021, then skyrocketed by 318.93% to $14.7 million in 2022, then crashed by 131.6% to -$4.6 million in 2023, then crashed by 5408.46% to -$255.8 million in 2024, then skyrocketed by 89.56% to -$26.7 million in 2025.
  • The last three reported values for Net Cash Flow were -$26.7 million (Q4 2025), -$26.3 million (Q3 2025), and -$15.0 million (Q2 2025) per Business Quant data.